These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 5040184

  • 21. Antiparkinsonian agents and fluphenazine decanoate.
    Idzorek S.
    Am J Psychiatry; 1976 Jan; 133(1):80-2. PubMed ID: 1247126
    [Abstract] [Full Text] [Related]

  • 22. Long-acting, antipsychotic agents and extrapyramidal side effects.
    Simpson GM.
    Dis Nerv Syst; 1970 Sep; 31():Suppl:12-4. PubMed ID: 5476354
    [No Abstract] [Full Text] [Related]

  • 23. Rigidity, hyperpyrexia and coma following fluphenazine enanthate.
    Meltzer HY.
    Psychopharmacologia; 1973 Sep; 29(4):337-46. PubMed ID: 4707025
    [No Abstract] [Full Text] [Related]

  • 24. Fluphenazine enanthate in sesame oil, a depot preparation.
    Rasmussen OS.
    Acta Psychiatr Scand; 1970 Sep; 46(3):311-8. PubMed ID: 5490593
    [No Abstract] [Full Text] [Related]

  • 25. Patients at risk of developing severe side effects from depot fluphenazine treatment.
    Blum A.
    Am J Psychiatry; 1980 Feb; 137(2):254-5. PubMed ID: 7352591
    [No Abstract] [Full Text] [Related]

  • 26. Letter: Choreiform movements after depot injections of flupenthixol.
    Carney MW.
    Br J Psychiatry; 1974 Dec; 125():609. PubMed ID: 4457212
    [No Abstract] [Full Text] [Related]

  • 27. Fluphenazine: twelve years' experience.
    Ayd FJ.
    Dis Nerv Syst; 1968 Nov; 29(11):744-7. PubMed ID: 5752634
    [No Abstract] [Full Text] [Related]

  • 28. Neuroleptics and the corpus striatum: clinical implications.
    Stimmel GL.
    Dis Nerv Syst; 1976 Apr; 37(4):219-24. PubMed ID: 1253676
    [No Abstract] [Full Text] [Related]

  • 29. Private ambulatory patients treated with fluphenazine enanthate.
    Kline NS, Simpson GM, Swenson JE.
    Dis Nerv Syst; 1970 Sep; 31():Suppl:43-5. PubMed ID: 5476357
    [No Abstract] [Full Text] [Related]

  • 30. Depot fluphenazine: risk/benefit ratio.
    Glazer WM.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [Abstract] [Full Text] [Related]

  • 31. [Prolonged action neuroleptics (review of the foreign literature)].
    Obukhov GA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975 May; 75(2):285-95. PubMed ID: 235182
    [No Abstract] [Full Text] [Related]

  • 32. Institutional management of chronic schizophrenics with fluphenazine decanoate.
    Neal CD, Imlah NW.
    Dis Nerv Syst; 1970 Sep; 31():Suppl:24-7. PubMed ID: 4920310
    [No Abstract] [Full Text] [Related]

  • 33. [Long-action neuroleptic agents (delayed-action neuroleptics)].
    Ginestet D, Péron-Magnan P.
    Rev Prat; 1972 Apr 21; 22(12):1941-53. PubMed ID: 4675045
    [No Abstract] [Full Text] [Related]

  • 34. A controlled study of neuroleptization with fluphenazine hydrochloride injections.
    Escobar JI, Barron A, Kiriakos R.
    J Clin Psychopharmacol; 1983 Dec 21; 3(6):359-62. PubMed ID: 6139394
    [No Abstract] [Full Text] [Related]

  • 35. Fluphenazine hydrochloride, enanthate, and decanoate in the management of chronic psychosis.
    Itil T, Keskiner A.
    Dis Nerv Syst; 1970 Sep 21; 31():Suppl:37-42. PubMed ID: 4920313
    [No Abstract] [Full Text] [Related]

  • 36. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT, Hoerdt HP.
    Ann Med Psychol (Paris); 1972 Feb 21; 1(2):277-83. PubMed ID: 5051257
    [No Abstract] [Full Text] [Related]

  • 37. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug 21; 14(3):182-5. PubMed ID: 7333179
    [No Abstract] [Full Text] [Related]

  • 38. The use of fluphenazine enanthate in psychotic patients.
    Routsonis KG, Photiadis H.
    Curr Ther Res Clin Exp; 1973 Mar 21; 15(3):92-6. PubMed ID: 4196232
    [No Abstract] [Full Text] [Related]

  • 39. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ.
    J Clin Psychiatry; 1984 May 21; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [Abstract] [Full Text] [Related]

  • 40. Antiparkinsonian agents and depot phenothiazine.
    Chien CP, Dimascio A, Cole JO.
    Am J Psychiatry; 1974 Jan 21; 131(1):86-90. PubMed ID: 4808437
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.